Our ability to design complex synthetic materials is changing many aspects of our life. However, the novelty of such designer materials begs the question of their risks.
Content of the collaboration
15 Jan 2014
Learn more about the objectives of SEARCH and how the collaboration came about.
What sources is the research project using?
We build on existing pioneering studies, such as the multiple versions of the CHD Impact Model and Global Burden of Disease (GBoD) projects. The CHD risk factor analysis and future projections published by Simon Capewell work as a template for structuring the expected research results. All Swiss Re Fellows have access to a variety of cohorts and data sets for their respective risk factor and country analyses. Fellows have identified over 30 diverse data sources such as government population health surveillance data, cohort studies, and other accessible databases.
Why are HSPH and Swiss Re so interested in emerging economies?
- Emerging/high growth markets are fast expanding and rapidly growing their middle class. There is a concurrent growth in many markets in demand for life and health insurance policies.
- As economies become more prosperous, there are rapid shifts in their human behaviour and health profiles, most notably a shift from infectious to non-communicable diseases.
- Emerging/high growth markets frequently lack the depth and sophistication of data currently found in many industrial economies.
Why is the focus on cardiovascular disease?
- It is is the biggest cause of death in major emerging/high growth economies.
- It is closely associated with an established range of causal factors, including inactivity, smoking and diet.
- Altering causal factors for cardiovascular disease will have a significant effect on mortality. Factors include smoking bans, urban and housing designs that encourage physical activity, and emergency responses to coronary events.
What will the sponsoring bodies do with the results?
Swiss Re: The results will be used to build forward-looking morbidity and mortality models to assess current and future life and health business.
HSPH: Their objective is to develop and test preventive health measures, and to shape global health policies.